Open AccessDurable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Author(s) -
Howard L. Kaufman,
Robert H.I. Andtbacka,
Frances A. Collichio,
Michael S. Wolf,
Zhongyun Zhao,
Mark Shilkrut,
Igor Puzanov,
Merrick I. Ross
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/x0k6-s254
Subject(s) - oncolytic virus , immunotherapy , clinical trial , cancer immunotherapy , cancer , medicine , oncology , clinical endpoint , virology